Envestnet Asset Management Inc Neuronetics, Inc. Transaction History

Envestnet Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$2.74 - $6.87 $9,995 - $25,061	3,648 Added 2.94%	127,680 $877,000
Q3 2022 Nov 10, 2022	BUY	$2.35 - $4.66 $41,425 - $82,146	17,628 Added 16.57%	124,032 $394,000
Q2 2022 Aug 03, 2022	BUY	$2.09 - $3.71 $53,489 - $94,950	25,593 Added 31.67%	106,404 $342,000
Q1 2022 May 04, 2022	BUY	$2.84 - $4.52 $130,435 - $207,594	45,928 Added 131.66%	80,811 $245,000
Q4 2021 Feb 04, 2022	BUY	$3.87 - $6.59 $52,109 - $88,734	13,465 Added 62.87%	34,883 $156,000
Q3 2021 Oct 07, 2021	BUY	$6.22 - $15.54 $19,095 - $47,707	3,070 Added 16.73%	21,418 $141,000
Q2 2021 Aug 04, 2021	BUY	$10.15 - $17.25 $76,084 - $129,306	7,496 Added 69.07%	18,348 $294,000
Q1 2021 May 04, 2021	BUY	$10.6 - $21.27 $115,031 - $230,822	10,852 New	10,852 $134,000

18.3M

3.8K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $20.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.